- Tezepelumab - a novelty in the treatment of severe asthma2023 | Faculty of Medicine in Pilsen
- Tezepelumab: a promising future for patients with severe asthma2022 | Third Faculty of Medicine
- Alarmins - novel targets for biological therapy2023 | Faculty of Medicine in Hradec Králové
- New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis2023 | First Faculty of Medicine, Second Faculty of Medicine